Top section
Top section
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Despite rough market conditions and angst over rates, array of deals have been well taken
It is difficult to see issuance conditions growing much better in the foreseeable future
Data
More articles
More articles
More articles
-
More and more Chinese issuers are using the Covid-19 pandemic as a convenient excuse to justify missed or delayed payments of bonds. The trend needs to stop. -
China-based Kintor Pharmaceutical has kicked off bookbuilding for its Hong Kong listing, the latest in a stream of healthcare IPOs in the city. The issuer is targeting HK$1.86bn ($240.1m) in proceeds.
-
Argentina’s dollar bonds climbed again on Monday after the issuer extended the deadline for a restructuring offer, as a change in tone from the government offered slight hope that an agreement can be reached.
-
Emerging market loan volumes have declined further amid the panic and uncertainty that Covid-19 has plunged the market into. Loan bankers show little optimism and say that the second quarter will likely resemble the first.
-
The Republic of Serbia hit euro markets on Monday as it worked to stack up funding for its fight against the Covid-19 coronavirus, selling a seven year bond.
-
Peijia Medical bagged HK$2.34bn ($302m) from its IPO after winning huge support from institutional and retail investors, according to a source close to the deal.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
